Stephen Broderick

12.7k citations
89 papers · 10k · 6 hit papers · h-index 35

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Cancer Cells and Metastasis
    • COVID-19 and healthcare impacts

Papers in

    • Lung Cancer Diagnosis and Treatment 42
    • Lung Cancer Treatments and Mutations 8
    • Pleural and Pulmonary Diseases 2
    • Cancer Immunotherapy and Biomarkers 16
    • COVID-19 and healthcare impacts 3

Stephen Broderick

88 papers receiving 9.8k citations

Stephen Broderick's Hit Papers

Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer 2025 · 77 citations
770+6+12Years since publication5001k1.5k2k

Peers

Stephen Broderick
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 4.8k
  • Oncology 2.8k
  • Cancer Research 1.1k
  • Molecular Biology 1.3k
  • Surgery 703
Replace Fernando López‐Ríos with:
Fernando López‐Ríos Spain
Pankaj Vats United States
Chung‐Han Lee United States
Nina Tunariu United Kingdom
Noriko Motoi Japan
Ajjai Shivaram Alva United States
Marie Christine Aubry United States
Erich Stoelben Germany
Thomas Filleron France
Ichiro Kinoshita Japan
Stephen Broderick relative to Fernando López‐Ríos Spain Fernando López‐Ríos's profile →
Citations per field
00.5×1.5×
Fernando López‐Ríos · 1×
Citations per year

Countries citing papers authored by Stephen Broderick

Since Specialization
Citations

This map shows the geographic impact of Stephen Broderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Broderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Broderick more than expected).

Fields of papers citing papers by Stephen Broderick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Broderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Broderick. The network helps show where Stephen Broderick may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Broderick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Broderick Line = papers co-authored together Stephen Broderick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Somatic mutations affect key pathways in lung adenocarcinoma
Hit paper breakdown →
20082237
2
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Hit paper breakdown →
20181663
3
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Hit paper breakdown →
20071431
4
Characterizing the cancer genome in lung adenocarcinoma
Hit paper breakdown →
2007929
5 2020275
6 2018230
7 2008228
8 2009198
9 2015173
10 2017145
11 2020141
12 2014104
13
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Hit paper breakdown →
202494
14
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
200792
15 201583
16 202083
17 201481
18 200780
19 201578
20 202078

About Stephen Broderick

Stephen Broderick is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Health Information Management and Cancer Research, having authored 89 papers that have together received 10k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (42 papers), Cancer Immunotherapy and Biomarkers (16 papers), Esophageal Cancer Research and Treatment (14 papers), Lung Cancer Treatments and Mutations (8 papers), Transplantation: Methods and Outcomes (5 papers), Healthcare Quality and Management (3 papers), COVID-19 and healthcare impacts (3 papers) and Pleural and Pulmonary Diseases (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.8k citations), Oncology (2.8k citations), Cancer Research (1.1k citations), Molecular Biology (1.3k citations) and Surgery (703 citations). Stephen Broderick has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Bryan Fitch Meyers, Varun Puri, G. Alexander Patterson, Traves D. Crabtree, Daniel Kreisel, Alexander Sasha Krupnick, Aalok P. Patel, Pamela Parker Samson, Valerie W. Rusch and Jennifer M. Bell. Their work appears in journals such as The Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Thoracic Oncology, Lung Cancer and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact